Dna X (SONM) Gross Profit (2018 - 2025)

Dna X's Gross Profit history runs 8 years deep, the most recent figure standing at -$2.8 million for Q4 2025.

• Quarterly Gross Profit fell 1434.43% year-over-year to -$2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.2 million (down 17.25% YoY) and the FY2025 annual result came in at $8.2 million, down 17.25% from the prior year.
• Gross Profit was -$2.8 million for Q4 2025 at Dna X, down from $1.8 million in the prior quarter.
• Across five years, Gross Profit topped out at $8.4 million in Q1 2025 and bottomed at -$2.8 million in Q4 2025.
• A 5-year average of $2.8 million and a median of $2.9 million in 2022 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2022 — Gross Profit soared 907.39% — and 2025, when it tumbled 1434.43%.
• Dna X's Gross Profit stood at -$487000.0 in 2021, then surged by 907.39% to $3.9 million in 2022, then surged by 30.21% to $5.1 million in 2023, then plunged by 103.57% to -$183000.0 in 2024, then tumbled by 1434.43% to -$2.8 million in 2025.
• Business Quant data shows SONM's Gross Profit at -$2.8 million in Q4 2025, $1.8 million in Q3 2025, and $845000.0 in Q2 2025.